Enjaymo (Sutimlimab-jome) 1100mg/22mL – 6 Vials – Cold Agglutinin Disease Treatment

ENJAYMO (sutimlimab-jome) is a prescription medicine used to treat hemolysis in adults with Cold Agglutinin Disease (CAD). Specifically, ENJAYMO works by reducing the destruction of red blood cells (hemolysis) in adults with CAD, which helps decrease the need for red blood cell transfusions.

Product Specifications

Active Ingredient

Sutimlimab-jome

Indication

Cold Agglutinin Disease (CAD), Hemolysis management in adults

Strength

1100mg/22mL (50mg/mL)

Packaging

6 single-dose injection vials

Storage Temperature

Refrigerated (2°C to 8°C)

Why Choose Uno Healthcare?

Quality Assured

All products undergo rigorous quality checks and are sourced from certified manufacturers.

Global Shipping

Reliable logistics partners ensuring safe and timely delivery to your facility.

Expert Support

Dedicated team available to assist with product inquiries and order management.